NCT01878344View on ClinicalTrials.gov

Effects of N-acetyl Cysteine During Primary Percutaneous Coronary Intervention

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

January 31, 2018

Study Completion Date

December 31, 2026

Conditions
Acute ST Segment Elevation Myocardial Infarction
Interventions
DRUG

NAC

DRUG

Saline

Trial Locations (1)

32260

Suleyman Demirel University, Isparta

All Listed Sponsors
lead

Suleyman Demirel University

OTHER

NCT01878344 - Effects of N-acetyl Cysteine During Primary Percutaneous Coronary Intervention | Biotech Hunter | Biotech Hunter